Ligand Pharmaceuticals Incorporated
LGND · Healthcare · $6.3B
$303.52-2.83%
Price
$319.6
$302.0
Jul 2, 26Oct 1, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$78M+22.6%
6/'26 vs prev quarter
Company Health
Market Cap$6.3B
Operating Margin+34.7%
Cash on Hand$1.7B27.3% of market cap
Free Cash Flow$131M2.1% of market cap
Short Float 7.7% · biweekly · settled 26.05.15
Among 327 Biotechnology peers
LowMedianHigh
PSR21.6xmedian 11.7xPER31.7xmedian 14.9xPBR6.5xmedian 2.1xROE+20.4%median -54.5%
